16.95USD-3.09%Mkt Cap: 1.88B USDP/E: —Last update: 2026-06-01
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a diff…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.88B USD
Enterprise Value1.24B USD
Revenue (TTM)70.92M USD
Gross Profit-268.72M USD
Net Income (TTM)-342.60M USD
Revenue/Share0.7880 USD
Last Price16.95 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees252
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.02
PEG—
EV/EBITDA-3.22
EV/Revenue17.48
P/S27.44
P/B3.04
EPS (TTM)-3.35
EPS (Forward)-2.51
52W Range
13.1818% of range34.29
52W High34.29 USD
52W Low13.18 USD
Profitability
Gross Margin0.00%
Oper. Margin-82389.36%
EBITDA Margin0.00%
Profit Margin-483.57%
ROE-47.44%
ROA-38.09%
Growth
Revenue Growth95.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-276.39M USD
CapEx (TTM)495.00K USD
FCF Margin-257.41%
FCF Yield-9.73%
Net Debt-708.83M USD
Net Debt/EBITDA1.84
Balance Sheet
Debt/Equity0.07
Current Ratio15.15
Quick Ratio14.71
Book Value/Sh5.795 USD
Cash/Share7.394 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 13, 2020
Splits
Last Split1:15
Split DateNov 13, 2020
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)33.94 USD
Target Range20.00 USD – 50.00 USD
# Analysts16
Ownership
Shares Out.110.43M
Float103.02M
Insiders0.14%
Institutions109.75%
Short Interest
Short Ratio4.5d
Short % Float13.40%
Short % Out.12.92%
Shares Short14.27M
Short (prev mo.)10.66M
Technical
SMA 5017.57 (-3.5%)
SMA 20024.32 (-30.3%)
Beta0.82
S&P 52W Chg27.70%
Avg Vol (30d)2.81M
Avg Vol (10d)1.86M
Technical Indicators
RSI (14)53.4
MACD0.0793
MACD Signal-0.1590
MACD Hist.+0.2383
BB Upper19.27 USD
BB Middle16.84 USD
BB Lower14.41 USD
BB Width28.88%
ATR (14)0.9372 USD
Vol Ratio (20d)0.17x